← Back to Search

Conversational Voice Assistants for Loneliness

N/A
Recruiting
Led By Marcia Y Shade, PhD, RN
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Men and women≥60 years of age
Have experienced or currently experiencing musculoskeletal pain
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at day one and after 12-weeks
Awards & highlights

Study Summary

This trial will study the feasibility and efficacy of a conversational voice assistant (CVA) loneliness routine delivered through a CVA, with the aim of reducing loneliness and secondary outcomes in older adults that live alone and self-report pain.

Who is the study for?
This trial is for men and women aged 60 or older who live alone, have musculoskeletal pain, and can access the internet at home. They must be able to speak English and willing to use a voice assistant but haven't used one before.Check my eligibility
What is being tested?
The study tests if conversational voice assistants can reduce loneliness and pain in older adults living alone. It compares a standard routine with a personalized one over 12 weeks to see which is more effective.See study design
What are the potential side effects?
There are no direct medical side effects since this isn't a drug trial. However, participants may experience frustration or discomfort using new technology, depending on their familiarity with voice assistants.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 60 years old or older.
Select...
I am experiencing pain in my muscles or joints.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and after 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brief Pain Inventory
University of California Los Angeles (UCLA) Loneliness Scale
Secondary outcome measures
Customer Satisfaction
Depressive symptoms
Self-efficacy of managing pain
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Conversational Voice Assistant-StandardExperimental Treatment1 Intervention
Participants will complete a standard interactive routine with the voice assistant.
Group II: Conversational Voice Assistant-EnhancedExperimental Treatment1 Intervention
Participants will complete a personalized and tailored interactive routine with the voice assistant.

Find a Location

Who is running the clinical trial?

University of NebraskaLead Sponsor
539 Previous Clinical Trials
1,144,674 Total Patients Enrolled
Marcia Y Shade, PhD, RNPrincipal InvestigatorUniversity of Nebraska
Marcia ShadePrincipal InvestigatorUNMC

Media Library

Conversational Voice Assistant-Enhanced Clinical Trial Eligibility Overview. Trial Name: NCT05387447 — N/A
Loneliness Research Study Groups: Conversational Voice Assistant-Standard, Conversational Voice Assistant-Enhanced
Loneliness Clinical Trial 2023: Conversational Voice Assistant-Enhanced Highlights & Side Effects. Trial Name: NCT05387447 — N/A
Conversational Voice Assistant-Enhanced 2023 Treatment Timeline for Medical Study. Trial Name: NCT05387447 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the size of the cohort participating in this experiment?

"Affirmative, based on the data hosted by clinicaltrials.gov, this medical investigation is still looking for enrollees since its initial posting date of March 1st, 2022. 60 individuals are needed to be recruited from 4 sites."

Answered by AI

What are the objectives of this experiment?

"The primary outcome of this clinical trial, to be measured over a 12 week period, is based on the UCLA Loneliness Scale. Secondary evaluations include Customer Satisfaction, Depressive Symptoms and Self-Efficacy for Pain management."

Answered by AI

Is this experiment currently taking on new participants?

"Affirmative. According to clinicaltrials.gov, this medical investigation is currently recruiting patients that began on March 1st 2022 and was recently updated on May 24th 2022; with a goal of enrolling 60 individuals from 4 distinct locations."

Answered by AI

Who else is applying?

What state do they live in?
Nebraska
How old are they?
18 - 65
What site did they apply to?
Aksarben Village Senior Apartments
What portion of applicants met pre-screening criteria?
Met criteria
~4 spots leftby Jun 2024